American Diabetes Association
American Diabetes Association urges Senate to pass stem cell bill
Published in Healthcare Finance, Tax and Law Weekly, August 16th, 2006
The ADA has been a strong supporter of the bill, which would accelerate stem cell research by easing existing restrictions and supporting research that uses embryonic stem cells, while maintaining strict ethical guidelines. The fact is, many embryos that currently exist as part of infertility treatments are slated to be discarded. Rather than disposing of these embryos, they could be used to save millions of lives. The Senate will consider two other bills this week as part of the stem cell debate, Senate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Adams Respiratory Therapeutics
Adams Respiratory Therapeutics gets commitment for $50 million bank credit facility - Advanced Magnetics
Advanced Magnetics reports loss of $0.57 per share - Advanced Viral Research
Advanced Viral Research granted U.S. patent for rheumatoid arthritis - Alfacell
Alfacell announces common stock and warrant offering of $11.3 million - American Hospital Directory
Financial impact of Medicare IPPS ruling on hospitals available through ahd.com - Amgen
Amgen's earnings per share increased 19% to $1.05 - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
